19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      MicroRNAs in Liver Disease

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          MicroRNAs are small noncoding RNA molecules that regulate gene expression posttranscriptionally through complementary base pairing with thousands of messenger RNAs. They regulate diverse physiological, developmental, and pathophysiological processes. Recent studies have uncovered the contribution of microRNAs to the pathogenesis of many human diseases, including liver diseases. Moreover, microRNAs have been identified as biomarkers that can often be detected in the systemic circulation. We review the role of microRNAs in liver physiology and pathophysiology, focusing on viral hepatitis, liver fibrosis, and cancer. We also discuss microRNAs as diagnostic and prognostic markers and microRNA-based therapeutic approaches for liver disease.

          Related collections

          Author and article information

          Journal
          0374630
          3841
          Gastroenterology
          Gastroenterology
          Gastroenterology
          0016-5085
          1528-0012
          19 December 2018
          11 April 2012
          June 2012
          29 December 2018
          : 142
          : 7
          : 1431-1443
          Affiliations
          [* ] Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer institute, National Institutes of Health, Bethesda, Maryland
          [] Department of Clinical Biochemistry and Immunology Statens Serum Institut, Copenhagen, Denmark
          [§ ] Santaris Pharma, Kogle Allé 6, Hørsholm, Denmark
          Author notes
          Reprint requests Address requests for reprints to: Xin Wei Wang, PhD, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892; xw3u@ 123456nih.gov ; Niels H. H. Heegaard, MD, DSc, Department of Clinical Biochemistry and Immunology, Statens Serum Institut, Copenhagen, Denmark;; Henrik Ørum, PhD, Santaris Pharma, Hørsholm, Denmark.; nhe@ 123456ssi.dk hoe@ 123456santaris.com .
          Article
          PMC6311104 PMC6311104 6311104 nihpa1002412
          10.1053/j.gastro.2012.04.007
          6311104
          22504185
          497d0797-5b20-4f54-93d1-5732f2a9dfbe
          History
          Categories
          Article

          Chronic Liver Disease,Liver Fibrosis,Cirrhosis,Hepatocellular Carcinoma

          Comments

          Comment on this article